Risedronate Sodium

Risedronate Sodium   CAS No. 115436-72-1      

The drug is used for the treatment of osteoporosis in postmenopausal women, general dosage forms are tablet and injection.

Quality Standard: CP2005

Assay: ＞99%

Total substance:＜1.0%

Individual impurity:＜0.5%

Appearance: white powder

Packaging: 1kg/aluminum tin; 25kg/carton barrel

Capacity: commercialization, 500kg/yr

Delivery time: 1-50kg, prompt shipment; ＞50kg，should be negotiated.

Documentation: DMF (Open Part)

• 2,6-Dimethylmorpholine
• Cis-2,6-dimethylmorpholine
• Amorolfine HCL
• Ondansetron HCl
• Entecavir
• 2-(2-methoxy phenoxy)ethylamine Hydrochloride
• 5-Methylbenzimidazole
• Piperidinooxy,4-hydroxy-2,2,6,6-tetramethyl-,sebacate
• Memantine HCL
• Alfuzosin HCL